JP2002537352A5 - - Google Patents

Download PDF

Info

Publication number
JP2002537352A5
JP2002537352A5 JP2000600684A JP2000600684A JP2002537352A5 JP 2002537352 A5 JP2002537352 A5 JP 2002537352A5 JP 2000600684 A JP2000600684 A JP 2000600684A JP 2000600684 A JP2000600684 A JP 2000600684A JP 2002537352 A5 JP2002537352 A5 JP 2002537352A5
Authority
JP
Japan
Prior art keywords
neisseria
composition
symbiotic
extract
kda
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000600684A
Other languages
English (en)
Japanese (ja)
Other versions
JP4982009B2 (ja
JP2002537352A (ja
Filing date
Publication date
Priority claimed from GBGB9904028.9A external-priority patent/GB9904028D0/en
Priority claimed from GBGB9922561.7A external-priority patent/GB9922561D0/en
Application filed filed Critical
Priority claimed from PCT/GB2000/000624 external-priority patent/WO2000050074A2/en
Publication of JP2002537352A publication Critical patent/JP2002537352A/ja
Publication of JP2002537352A5 publication Critical patent/JP2002537352A5/ja
Application granted granted Critical
Publication of JP4982009B2 publication Critical patent/JP4982009B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2000600684A 1999-02-22 2000-02-22 ナイセリアワクチン組成物および方法 Expired - Fee Related JP4982009B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB9904028.9 1999-02-22
GBGB9904028.9A GB9904028D0 (en) 1999-02-22 1999-02-22 Neisserial vaccine
GBGB9922561.7A GB9922561D0 (en) 1999-09-23 1999-09-23 Neisserial vaccine compositions and methods
GB9922561.7 1999-09-23
PCT/GB2000/000624 WO2000050074A2 (en) 1999-02-22 2000-02-22 Neisserial vaccine compositions and methods

Publications (3)

Publication Number Publication Date
JP2002537352A JP2002537352A (ja) 2002-11-05
JP2002537352A5 true JP2002537352A5 (enExample) 2007-03-01
JP4982009B2 JP4982009B2 (ja) 2012-07-25

Family

ID=26315168

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000600684A Expired - Fee Related JP4982009B2 (ja) 1999-02-22 2000-02-22 ナイセリアワクチン組成物および方法

Country Status (12)

Country Link
US (1) US7157245B2 (enExample)
EP (2) EP1852125A3 (enExample)
JP (1) JP4982009B2 (enExample)
AT (1) ATE386541T1 (enExample)
AU (1) AU779086B2 (enExample)
CA (1) CA2371928C (enExample)
CY (1) CY1107950T1 (enExample)
DE (1) DE60038099T2 (enExample)
DK (1) DK1154791T3 (enExample)
ES (1) ES2298128T3 (enExample)
PT (1) PT1154791E (enExample)
WO (1) WO2000050074A2 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1154791T3 (da) * 1999-02-22 2008-06-16 Health Prot Agency Neisseria-vaccinesammensætninger og fremgangsmåder
US7081244B2 (en) * 1999-02-22 2006-07-25 Health Protection Agency Neisserial vaccine compositions and methods
GB0007433D0 (en) * 2000-03-27 2000-05-17 Microbiological Res Authority Recombinant transferrin binding proteins
GB0107219D0 (en) * 2001-03-22 2001-05-16 Microbiological Res Authority Immunogenic commensal neisseria sequences
GB0130123D0 (en) 2001-12-17 2002-02-06 Microbiological Res Agency Outer membrane vesicle vaccine and its preparation
EP1374892A1 (en) * 2002-06-28 2004-01-02 Braun, Jan Matthias, Dr. Medicament for the treatment of diseases due to infection by Neisseria Meningitidis
GB0220194D0 (en) 2002-08-30 2002-10-09 Chiron Spa Improved vesicles
WO2005030122A2 (en) * 2003-08-13 2005-04-07 Chiron Corporation Inactivated host cell delivery of polynucleotides encoding immunogens
GB0424092D0 (en) 2004-10-29 2004-12-01 Chiron Srl Immunogenic bacterial vesicles with outer membrane proteins
US9387239B2 (en) 2008-05-30 2016-07-12 U.S. Army Medical Research And Materiel Command Meningococcal multivalent native outer membrane vesicle vaccine, methods of making and use thereof
GB0916557D0 (en) 2009-09-21 2009-10-28 Health Prot Agency Commensal neisserial stress protein complexes
GB0922224D0 (en) 2009-12-21 2010-02-03 Hiltech Developments Ltd Transformation of commensal neisseria
US10900043B2 (en) 2014-09-02 2021-01-26 Arizona Board Of Regents On Behalf Of The University Of Arizona Compositions and methods for treating bacterial disease
US10286016B2 (en) 2014-09-02 2019-05-14 Arizona Board Of Regents On Behalf Of The University Of Arizona Compositions and methods for treating gonorrhea
GB201522153D0 (en) * 2015-12-15 2016-01-27 Univ Southampton Meningococcal infection and modified neisseria lactamica
US12005110B2 (en) 2019-02-14 2024-06-11 University Of Florida Research Foundation, Incorporated Honeybee commensal Snodgrassella alvi vaccine against pathogenic Neisseriaceae

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5288617A (en) 1984-10-31 1994-02-22 Commonwealth Scientific And Industrial Research Organization Method of producing an antigenic preparation
US6737521B1 (en) * 1990-05-11 2004-05-18 The Rockefeller University Delivery and expression of a hybrid surface protein on the surface of gram positive bacteria
US5439808A (en) 1993-07-23 1995-08-08 North American Vaccine, Inc. Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis
US5470740A (en) * 1993-11-04 1995-11-28 Life Technologies, Inc. Cloned NsiI restriction-modification system
IL117483A (en) * 1995-03-17 2008-03-20 Bernard Brodeur MENINGITIDIS NEISSERIA shell protein is resistant to proteinase K.
US5980912A (en) 1997-03-25 1999-11-09 Zonagen, Inc. Chitosan induced immunopotentiation
GB9811260D0 (en) * 1998-05-26 1998-07-22 Smithkline Beecham Biolog Novel compounds
GB9823978D0 (en) * 1998-11-02 1998-12-30 Microbiological Res Authority Multicomponent meningococcal vaccine
US20030215469A1 (en) * 1998-11-02 2003-11-20 Microbiological Research Authority Multicomponent meningococcal vaccine
US6413768B1 (en) * 1998-12-02 2002-07-02 University Of Maryland Expression plasmids
JP2003506007A (ja) * 1998-12-02 2003-02-18 ユニヴァーシティ オブ メリーランド，ボルチモア 抗原送達用プラスミド維持系
US7081244B2 (en) * 1999-02-22 2006-07-25 Health Protection Agency Neisserial vaccine compositions and methods
DK1154791T3 (da) * 1999-02-22 2008-06-16 Health Prot Agency Neisseria-vaccinesammensætninger og fremgangsmåder
GB0130123D0 (en) * 2001-12-17 2002-02-06 Microbiological Res Agency Outer membrane vesicle vaccine and its preparation

Similar Documents

Publication Publication Date Title
AU2002350974B2 (en) Outer membrane vesicles from gram negative bacteria and use as a vaccine
TWI281403B (en) Vaccine
JP2002537352A5 (enExample)
US6558677B2 (en) Vaccine against gram negative bacteria
US6355253B1 (en) Preparation and uses of LOS-depleted outer membrane proteins of gram-negative cocci
JP3860208B2 (ja) 非毒性口内アジュバントとして有効な突然変異エンテロトキシン
US9707286B2 (en) Process for detergent-free production of outer membrane vesicles of a gram-negative bacterium
JP2020203950A (ja) 肺炎球菌ワクチンにおいて用いるための免疫原性組成物
CN1149835A (zh) 甲型链球菌多糖免疫原性组合物及方法
JP2001510169A (ja) Ｂ型髄膜炎菌性ポーリンおよびＨ．ｉｎｆｌｕｅｎｚａｅ多糖体を含む免疫原性結合体
CN110248681A (zh) nOMV-抗原缀合物及其用途
US20180214541A1 (en) Haemophilus influenzae fusion protein and construction method and use thereof
De Moreno de LeBlanc et al. Oral administration of L. casei CRL 431 increases immunity in bronchus and mammary glands
JP2024178271A (ja) 腸疾患に対する免疫原性組成物およびその調製のための方法
CN119120335A (zh) 保护b群脑膜炎球菌感染的外膜囊泡组合物及制法和应用
RU2185191C1 (ru) Способ получения антигенного препарата haemophilus influenzae типа b (hib)
WO2004054611A1 (en) Meningococcal vaccine based on outer membrane proteins porb2 and pora
Zhu et al. Intranasal immunization of mice with recombinant lipidated P2086 protein reduces nasal colonization of group B Neisseria meningitidis
CN1288384A (zh) 用于预防哺乳动物粘膜炎莫拉氏(布拉汉氏)菌感染的脂寡糖疫苗
JPWO2018074296A1 (ja) 低分子化ＰＲＰを用いたＨｉｂコンジュゲートワクチンの製造方法
CN106075430A (zh) 多价肺炎球菌‑acyw135脑膜炎球菌联合疫苗
CN104096224B (zh) 一种增强流行性嗜血杆菌b型多糖蛋白结合物免疫原性的方法
CN112566658A (zh) 大肠杆菌组合物及其方法
CA2761924A1 (fr) Vaccin meningocoque a base de lipooligosaccharide (los) provenant de souches modifiees de neisseria meningitidis d'immunotype l6
Garcia et al. Optimization of Neisseria lactamica’s outer membrane vesicles production in batch cultivation process